The Cholangiocarcinoma Newsblast
- This topic has 10 replies, 4 voices, and was last updated 9 years, 11 months ago by
.
-
Posts
-
Ha,ha, Randi, count me in on the not under 50 group. Thanks for filling out the information.
Hugs,
MarionI filled out the initial form today. Unfortunately (for a lot of reasons) I am not under 50, but the Mayo does have my tissue sample and blood work on record there.
I will pass along the information.
-Randi-
I sent in my initial form earlier today and already had an email from the folks at the Mayo Clinic with the consent forms. I’m very excited about participating.
I have also forwarded the info to two friends who both lost parents to this dreadful disease and I hope that they will chose to submit records as well. I think it’s important. And, I still shake my head that such a rare cancer can strike one of my best college friend’s mother and a very close current work colleague’s father, as well as me. I didn’t know that either one had CC – just that they lost their parents to cancer. It was only when I told them my diagnosis that I learned of theirs. I think it’s time to talk about this in public a lot more.
I was delighted to have several friends email/text/call me about Melinda’s wonderful story about her NIH trial today. They were all over the country and reading different papers, but they all saw “bile duct cancer” and immediately thought of me.
Thanks for this Marion! So looking forward to reading and hearing more about how everything goes. The links that you posted don’t seem to work though for some reason. Are these what you were trying to post?
http://www.linkedin.com/company/the-cholangiocarcinoma-foundation
https://www.facebook.com/cholangiocarcinoma
Apologies if I’m stepping on toes here!
Hugs to all,
Gavin
Most likely you will read this via numerous sources, but I thought to post it here as well:
Dear Patients, Family, Friends, Volunteers, Advocates and Supporters:
We need your immediate help to spread the word about important cholangiocarcinoma (bile duct cancer) research!
The Mayo Clinic, MD Anderson, Sloan Kettering, MGH, UCSF and The Cholangiocarcinoma Foundation are collaborating to sponsor vital research initiatives for all cholangiocarcinoma (bile duct cancer) patients to identify cancer causing genes.
In addition, a team of researchers from these institutions have collaborated to design a new study called Cholangiocarcinoma In The Young (CITY). The CITY initiative will allow researchers to study patients diagnosed with cholangiocarcinoma who are under 50 OR have additional family members affected by this cancer or other cancers. CITY was launched in response to the recent death of Christopher Wilke, (age 12) who was the first patient on record at Children’s Hospital Los Angeles — and among the youngest patients ever — to be diagnosed with cholangiocarcinoma.
Take Action
EVERY patient diagnosed with cholangiocarcinoma is critical to these studies. If you have cholangiocarcinoma or know someone who does, you can assist researchers NOW!
Learn more now
Register now
Follow Team Christopher
Stay Connected
Please connect with and engage your friends and communities through social media. Start a discussion and help us with these important research initiatives for ALL patients diagnosed with cholangiocarcinoma. Follow the Cholangiocarcinoma Foundation on http://www.cholangiocarcinoma.org/images/linkedin-16×16.png http://www.cholangiocarcinoma.org/images/Twitter-16×16.png http://www.cholangiocarcinoma.org/images/FaceBook_16x16.png
Thank you for your tremendous support!
The Cholangiocarcinoma Foundation
- The forum ‘Announcements’ is closed to new topics and replies.